Abstract
We analyzed the adverse events associated with an off-label use of arterial stents and CE-marked iliac vein stents for the treatment of iliac venous thromboembolism and investigated their relationships with the anatomical features of the iliac vein, to gain insights into the development of a better iliac vein stent. Reports of adverse events following the use of stents in the iliac vein were retrieved from the Manufacturer and User Facility Device Experience (MAUDE) database that contain suspected device-associated complications reported to the Food and Drug Administration. Data from 2006 to 2016 were investigated. The literature analysis was also conducted using PubMed, Cochrane Library, EMBASE, and Web of Science focusing on English articles published up to 4 October 2016. The analysis of 88 adverse events from the MAUDE database and 182 articles from the literature revealed that a higher number of adverse events had been reported following the use of arterial stents in the iliac vein compared to CE-marked iliac vein stents. While stent migration and shortening were reported only for the arterial stents, stent fracture and compression occurred regardless of the stent type, even though a vein does not pulsate. A study of the anatomical features of the iliac vein implies that bending, compression, and kink loads are applied to the iliac vein stents in vivo. For designing, developing, and pre-clinical testing of stents intended for use in the iliac vein, the above mechanical load environments induced by the anatomical features should be considered.
Similar content being viewed by others
References
Heit JA, Cohen AT, Anderson FA. Estimate annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US. Blood. 2005;106:910.
Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M. Venous thromboembolism (VTE) in Europe. Thromb Haemost. 2007;98:756–64.
Sakuma M, Nakamura M, Yamada N, Ota S, Shirato K, Nakano T, Ito M, Kobayashi T. Venous thromboembolism-deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, pulmonary embolism alone. Circ J. 2009;73:305–9.
May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957;8:419–27.
Mickley V, Schwagierek R, Rillinger N, Gorich J, Sunder-Plassmann L. Left iliac venous thrombosis caused by venous spur: treatment with thrombectomy and stent implantation. J Vasc Surg. 1998;28:492–7.
Jeon UB, Chung JW, Jae HJ, Kim HC, Kim SJ, Ha J, Park JH. May–Thurner syndrome complicated by acute iliofemoral vein thrombosis: helical CT venography for evaluation of long-term stent patency and changes in the iliac vein. AJR. 2010;195:751–7.
Cho H, Kim JW, Hong YS, Lim SH, Won JH. Stent compression in iliac vein compression syndrome associated with acute ilio-femoral deep vein thrombosis. Korean J Radiol. 2015;16:723–8.
Neglen P, Tackett TP Jr, Raju S. Venous stenting across the inguinal ligament. J Vasc Surg. 2008;48:1255–61.
Funatsu A, Shibata K, Yamamoto R, Ono T, Mizobuchi M, Yokouchi I, Kanbayashi D, Kobayashi T, Enjoji Y, Nakamura S. Initial and long term outcomes of stent implantation for iliac compression syndrome. J Cardiol. 2007;50:371–7.
Raju S, Tackett P Jr, Neglen P. Reinterventions for nonocclusive iliofemoral venous stent malfunctions. J Vasc Surg. 2009;49:511–8.
de Graaf R, de Wolf MA, Sailer AM, van Laanen J, Wittens C, Jalaie H. Iliocaval confluence stenting for chronic venous obstructions. Cardiovasc Interv Radiol. 2015;38:1198–204.
Gutzeit A, Zollikofer ChL, Dettling-Pizzolate M, Graf N, Largiader J, Binkert CA. Endovascular stent treatment for symptomatic benign iliofemoral venous occlusive disease: long-term results 1987–2009. Cardiovasc Interv Radiol. 2011;34:542–9.
Raju S, Ward M Jr, Kirk O. A modification of iliac vein stent technique. Ann Vasc Surg. 2014;28:1485–92.
El Feghaly M, Soula P, Rousseau H, Chaiban F, Otal P, Joffre F, Cerene A. Endovascular retrieval of two migrated venous stents by means of balloon catheters. J Vasc Surg. 1998;28:541–6.
Liu Z, Gao N, Shen L, Yang J, Zhu Y, Li Z, Si Y. Endovascular treatment for symptomatic iliac vein compression syndrome: a prospective consecutive series of 48 patients. Ann Vasc Surg. 2014;28:695–704.
Knipp BS, Ferguson E, Williams DM, Dasika NJ, Cwikiel W, Henke PK, Wakefield TW. Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg. 2007;46:743–9.
Raju S. Long-Term outcomes of stent placement for symptomatic nonthrombotic iliac vein compression lesions in chronic venous disease. J Vasc Interv Radiol. 2012;23:497–502.
Hartung O, Otero A, Boufi M, De Caridi G, Barthelemy P, Juhan C, Alimi YS. Mid-term results of endovascular treatment for symptomatic chronic nonmalignant iliocaval venous occlusive disease. J Vasc Surg. 2005;42:1138–44.
Mullens W, De Keyser J, Van Dorpe A, Meuris B, Flamenq W, Herregods MC, Van de Werf F. Migration of two venous stents into the right ventricle in a patient with May–Thurner syndrome. Inter J Cardiol. 2006;110:114–5.
Ashar RM, Huettl EA, Halligan R. Percutaneous retrieval of a wallstent from the pulmonary artery following stent migration from the iliac vein. J Interv Cardiol. 2002;15:101–6.
Kwak HS, Han YM, Lee YS, Jin GY, Chung GH. Stents in common iliac vein obstruction with acute ipsilateral deep venous thrombosis: early and late results. J Vasc Interv Radiol. 2005;16:815–22.
de Wolf MA, de Graaf R, Kurstjens RL, Pennix S, Jalaie H, Wittens CH. Short-term clinical experience with a dedicated venous nitinol stent: initial results with the sinus-venous stent. Eur J Vasc Endovasc Surg. 2015;50:1–9.
de Graaf R, van Laanen J, Sailer A, Tordoir J. Long segment recanalization and dedicated central venous stenting in an ultimate attempt to restore vascular access central vein outflow. J Vasc Access. 2014;15:109–13.
Bozkaya H, Cinar C, Ertugay S, Korkmaz M, Guneyli S, Posacioqlu H, Parildar M. Endovascular treatment of iliac vein compression (May–Thurner) syndrome: angioplasty and stenting with or without manual aspiration thrombectomy and catheter-directed thrombolysis. Ann Vasc Dis. 2005;8:21–8.
Ye K, Lu X, Jiang M, Yang X, Li W, Huang Y, Huang X, Lu M. Technical details and clinical outcomes of transpopliteal venous stent placement for postthrombotic chronic total occlusion of the iliofemoral vein. J Vasc Interv Radiol. 2014;25:925–32.
Holper P, Kotelis D, Attigah N, Hyhlik-Durr A, Bockler D. Longterm results after surgical thrombectomy and simultaneous stenting for symptomatic iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg. 2010;39:349–55.
Igari K, Kudo T, Toyofuku T, Jibiki M, Inoue Y. Surgical thrombectomy and simultaneous stenting for deep venous thrombosis caused by iliac vein compression syndrome (May–Thurner Syndrome). Ann Thoracic Cardiovasc Surg. 2014;20:995–1000.
Titus JM, Moise MA, Bena J, Lyden SP, Clair DG. Iliofemoral stenting for venous occlusive disease. J Vasc Surg. 2011;53:706–12.
Oguzkurt L, Tercan F, Pourbaqher MA, Kizilkilic O, Turkoz R, Boyvat F. Computed tomography findings in 10 cases of iliac vein compression (May–Thurner) syndrome. Eur J Radiol. 2005;55:421–5.
Kibbe MR, Ujiki M, Goodwin AL, Eskandari M, Yao J, Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg. 2004;39:937–43.
Takahashi N, Hosoi Y, Matsukura M, Nunokawa M, Kubota H. Influence of iliac vein compression on subsequent recanalization after deep venous thrombosis. J Jpn Coll Angiol. 2013;53:23–8.
Roddy SP. Percutaneous recanalization of total occlusions of the iliac vein. J Vasc Surg. 2009;50:360–8.
Comerota AJ, Grewal NK, Thakur S, Assi Z. Endovenectomy of common femoral vein and intraoperative iliac vein recanalization for chronic iliofemoral venous occlusion. J Vasc Surg. 2010;52:243–7.
O’Sullivan GJ, Semba CP, Bittner CA, Kee ST, Razavi MK, Sze DY, Dake MD. Endovascular management of iliac vein compression (May–Thurner) syndrome. J Vasc Interv Radiol. 2000;11:823–36.
Mahnkern AH, Thomson K, de Haan M, O’Sullivan GJ. CIRSE standards of practice guidelines on iliocaval stenting. Cardiovasc Interv Radiol. 2014;37:889–97.
Andrews RT, Venbrux AC, Magee CA, Bova DA. Placement of a flexible endovascular stent across the femoral joint: an in vivo study in the swine model. J Vasc Interv Radiol. 1999;10:1219–28.
Matsuhashi Y, Sameshima K, Yamamoto Y, Umezu M, Iwasaki K. Investigation of the influence of fluid dynamics on thrombus growth at the interface between a connector and tube. J Artif Organs. 2017;20:293–302.
Acknowledgements
This research was partially supported by the Research on Regulatory Science of Pharmaceuticals and Medical Devices from Japan Agency for Medical Research and development, AMED (no. 17mk0102087h0001), and Subsidy Program for Development of International Standards for Evaluation of Innovative Medical Devices and Regenerative Medicine Products, 2017 from Ministry of Health, Labour and Welfare, Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Shida, T., Umezu, M. & Iwasaki, K. Investigation of adverse events associated with an off-label use of arterial stents and CE-marked iliac vein stents in the iliac vein: insights into developing a better iliac vein stent. J Artif Organs 21, 254–260 (2018). https://doi.org/10.1007/s10047-018-1023-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-018-1023-8